MINI-FOCUS ISSUE: THE FONTAN PROCEDURE
Contemporary Outcomes After the Fontan ProcedureA Pediatric Heart Network Multicenter Study
Page A.W. Anderson, MD*,*,
Lynn A. Sleeper, ScD ,
Lynn Mahony, MD ,
Steven D. Colan, MD ,
Andrew M. Atz, MD||,
Roger E. Breitbart, MD ,
Welton M. Gersony, MD¶,
Dianne Gallagher, MS ,
Tal Geva, MD ,
Renee Margossian, MD ,
Brian W. McCrindle, MD, MPH#,
Stephen Paridon, MD**,
Marcy Schwartz, MD ,
Mario Stylianou, PhD ,
Richard V. Williams, MD ,
Bernard J. Clark, III, MD** for the Pediatric Heart Network Investigators
* Duke University Medical Center, Durham, North Carolina
New England Research Institutes, Watertown, Massachusetts
University of Texas Southwestern Medical Center, Dallas, Texas
Children's Hospital Boston, Boston, Massachusetts
|| Medical University of South Carolina, Charleston, South Carolina
¶ Columbia University Medical Center, New York, New York
# The Hospital for Sick Children, Toronto, Ontario, Canada
** Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
 National Heart, Lung, and Blood Institute, Bethesda, Maryland
 Primary Children's Medical Center, Salt Lake City, Utah.
Manuscript received September 18, 2007;
revised manuscript received January 17, 2008,
accepted January 26, 2008.
* Reprint requests and correspondence: Dr. Page A. W. Anderson, Duke University Medical Center, Research Park Building 2, Room 113, Box 3218, Durham, North Carolina 27710. (Email: ander005{at}mc.duke.edu).
Objectives: We characterized a large cohort of children who had a Fontan procedure, with measures of functional health status, ventricular size and function, exercise capacity, heart rhythm, and brain natriuretic peptide (BNP).
Background: The characteristics of contemporary Fontan survivors are not well described.
Methods: We enrolled 546 children (age 6 to 18 years, mean 11.9 years) and compared them within pre-specified anatomic and procedure subgroups. History and outcome measures were obtained within a 3-month period.
Results: Predominant ventricular morphology was 49% left ventricular (LV), 34% right ventricular (RV), and 19% mixed. Ejection fraction (EF) was normal for 73% of subjects; diastolic function grade was normal for 28%. Child Health Questionnaire mean summary scores were lower than for control subjects; however, over 80% of subjects were in the normal range. Brain natriuretic peptide concentration ranged from <4 to 652 pg/ml (median 13 pg/ml). Mean percent predicted peak O2 consumption was 65% and decreased with age. Ejection fraction and EF Z score were lowest, and semilunar and atrioventricular (AV) valve regurgitation were more prevalent in the RV subgroup. Older age at Fontan was associated with more severe AV valve regurgitation. Most outcomes were not associated with a superior cavopulmonary connection before Fontan.
Conclusions: Measures of ventricular systolic function and functional health status, although lower on average in the cohort compared with control subjects, were in the majority of subjects within 2 standard deviations of the mean for control subjects. Right ventricular morphology was associated with poorer ventricular and valvular function. Effective strategies to preserve ventricular and valvular function, particularly for patients with RV morphology, are needed.
Key Words: brain natriuretic peptide cardiac magnetic resonance diastolic function echocardiography exercise Fontan pediatric
|
Abbreviations and Acronyms
| | AV = atrioventricular | | BNP = brain natriuretic peptide | | BSA = body surface area | | CMR = cardiac magnetic resonance | | E = atrioventricular valve peak early diastolic inflow velocity | | E' = tissue Doppler peak early diastolic velocity | | EDV = end-diastolic volume | | EF = ejection fraction | | ESV = end-systolic volume | | FP = systemic ventricular flow propagation rate | | LV = left ventricle/ventricular | | RV = right ventricle/ventricular | | SV = stroke volume | | VAT = peak oxygen consumption at anaerobic threshold | | VO2
= oxygen consumption |
|
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Feinstein, D. W. Benson, A. M. Dubin, M. S. Cohen, D. M. Maxey, W. T. Mahle, E. Pahl, J. Villafane, A. B. Bhatt, L. F. Peng, et al.
Hypoplastic left heart syndrome current considerations and expectations.
J. Am. Coll. Cardiol.,
January 3, 2012;
59(1 Suppl):
S1 - S42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ando and Y. Takahashi
Long-Term Functional Analysis of the Atrioventricular Valve in Patients Undergoing Single Ventricle Palliation
Ann. Thorac. Surg.,
November 1, 2011;
92(5):
1767 - 1773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Mascio, S. K. Pasquali, J. P. Jacobs, M. L. Jacobs, and E. H. Austin III
Outcomes in adult congenital heart surgery: Analysis of the Society of Thoracic Surgeons Database
J. Thorac. Cardiovasc. Surg.,
November 1, 2011;
142(5):
1090 - 1097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N. Dean, D. G. Hillman, K. E. McHugh, and H. P. Gutgesell
Inpatient Costs and Charges for Surgical Treatment of Hypoplastic Left Heart Syndrome
Pediatrics,
November 1, 2011;
128(5):
e1181 - e1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Virzi, V. Pemberton, R. G. Ohye, S. Tabbutt, M. Lu, T. C. Atz, T. Barnard, C. Dunbar-Masterson, N. S. Ghanayem, J. P. Jacobs, et al.
Reporting adverse events in a surgical trial for complex congenital heart disease: The Pediatric Heart Network experience
J. Thorac. Cardiovasc. Surg.,
September 1, 2011;
142(3):
531 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Honjo, C. R. Atlin, L. Mertens, O. O. Al-Radi, A. N. Redington, C. A. Caldarone, and G. S. Van Arsdell
Atrioventricular valve repair in patients with functional single-ventricle physiology: Impact of ventricular and valve function and morphology on survival and reintervention
J. Thorac. Cardiovasc. Surg.,
August 1, 2011;
142(2):
326 - 335.e2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Atz, T. G. Travison, B. W. McCrindle, L. Mahony, M. Quartermain, R. V. Williams, R. E. Breitbart, M. Lu, E. Radojewski, R. Margossian, et al.
Late Status of Fontan Patients With Persistent Surgical Fenestration
J. Am. Coll. Cardiol.,
June 14, 2011;
57(24):
2437 - 2443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Alsoufi, F. Alfadley, A. Al-Omrani, A. Awan, M. Al-Ahmadi, M. Al-Fayyadh, Z. Al-Halees, and C. C. Canver
Hybrid Management Strategy for Percutaneous Fontan Completion Without Surgery: Early Results
Ann. Thorac. Surg.,
February 1, 2011;
91(2):
566 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Auerbach, M. E. Richmond, L. J. Addonizio, J. M. Lamour, D. T. Hsu, E. D. Blume, R. E. Shaddy, L. Mahony, and E. Pahl
Response to Letter Regarding Article, "BNP Levels Predict Outcome in Pediatric Heart Failure Patients: Post Hoc Analysis of the Pediatric Carvedilol Trial"
Circ Heart Fail,
November 1, 2010;
3(6):
e33 - e33.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Myers, K. Ballman, L. E. Riegle, K. D. Mattix, K. Litwak, and M. D. Rodefeld
Mechanisms of systemic adaptation to univentricular Fontan conversion
J. Thorac. Cardiovasc. Surg.,
October 1, 2010;
140(4):
850 - 856.e6.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Stephenson, M. Lu, C. I. Berul, S. P. Etheridge, S. F. Idriss, R. Margossian, J. H. Reed, A. Prakash, L. A. Sleeper, V. L. Vetter, et al.
Arrhythmias in a Contemporary Fontan Cohort: Prevalence and Clinical Associations in a Multicenter Cross-Sectional Study
J. Am. Coll. Cardiol.,
September 7, 2010;
56(11):
890 - 896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sathanandam, A. C. Polimenakos, C. Blair, C. El Zein, and M. N. Ilbawi
Hypoplastic Left Heart Syndrome: Feasibility Study for Patients Undergoing Completion Fontan at or Prior to Two Years of Age
Ann. Thorac. Surg.,
September 1, 2010;
90(3):
821 - 829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Rodefeld, B. Coats, T. Fisher, G. A. Giridharan, J. Chen, J. W. Brown, and S. H. Frankel
Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump
J. Thorac. Cardiovasc. Surg.,
September 1, 2010;
140(3):
529 - 536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Salazar, F. Zafar, K. Siddiqui, R. D. Coleman, D. L. S. Morales, J. S. Heinle, J. W. Rossano, E. B. Mossad, and C. D. Fraser Jr.
Fenestration during Fontan palliation: Now the exception instead of the rule.
J. Thorac. Cardiovasc. Surg.,
July 1, 2010;
140(1):
129 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Beghetti
Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies
Heart,
June 1, 2010;
96(12):
911 - 916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Rathod, A. Prakash, A. J. Powell, and T. Geva
Myocardial Fibrosis Identified by Cardiac Magnetic Resonance Late Gadolinium Enhancement Is Associated With Adverse Ventricular Mechanics and Ventricular Tachycardia Late After Fontan Operation
J. Am. Coll. Cardiol.,
April 20, 2010;
55(16):
1721 - 1728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Robbers-Visser, M. Miedema, A. Nijveld, E. Boersma, A. J. J. C. Bogers, F. Haas, W. A. Helbing, and L. Kapusta
Results of staged total cavopulmonary connection for functionally univentricular hearts; comparison of intra-atrial lateral tunnel and extracardiac conduit
Eur J Cardiothorac Surg,
April 1, 2010;
37(4):
934 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Pemberton, B. W. McCrindle, S. Barkin, S. R. Daniels, S. E. Barlow, H. J. Binns, M. S. Cohen, C. Economos, M. S. Faith, S. S. Gidding, et al.
Report of the National Heart, Lung, and Blood Institute's Working Group on Obesity and Other Cardiovascular Risk Factors in Congenital Heart Disease
Circulation,
March 9, 2010;
121(9):
1153 - 1159.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sreeram, M. Emmel, U. Trieschmann, M. Kruessell, K. Brockmeier, L. B. Mime, and G. Bennink
Reopening acutely occluded cavopulmonary connections in infants and children
Interact CardioVasc Thorac Surg,
March 1, 2010;
10(3):
383 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Graham Jr
The Year in Congenital Heart Disease
J. Am. Coll. Cardiol.,
January 12, 2010;
55(2):
147 - 155.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. McCrindle, V. Zak, L. A. Sleeper, S. M. Paridon, S. D. Colan, T. Geva, L. Mahony, J. S. Li, R. E. Breitbart, R. Margossian, et al.
Laboratory Measures of Exercise Capacity and Ventricular Characteristics and Function Are Weakly Associated With Functional Health Status After Fontan Procedure
Circulation,
January 5, 2010;
121(1):
34 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prakash, A. J. Powell, and T. Geva
Multimodality Noninvasive Imaging for Assessment of Congenital Heart Disease
Circ Cardiovasc Imaging,
January 1, 2010;
3(1):
112 - 125.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. d'Udekem, M. M.H. Cheung, S. Setyapranata, A. J. Iyengar, P. Kelly, N. Buckland, L. E. Grigg, R. G. Weintraub, A. Vance, C. P. Brizard, et al.
How Good Is a Good Fontan? Quality of Life and Exercise Capacity of Fontans Without Arrhythmias
Ann. Thorac. Surg.,
December 1, 2009;
88(6):
1961 - 1969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Lambert, L. L. Minich, J. W. Newburger, M. Lu, V. L. Pemberton, E. A. McGrath, A. M. Atz, M. Xu, E. Radojewski, D. Servedio, et al.
Parent- Versus Child-Reported Functional Health Status After the Fontan Procedure
Pediatrics,
November 1, 2009;
124(5):
e942 - e949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Hsu and G. D. Pearson
Heart Failure in Children: Part II: Diagnosis, Treatment, and Future Directions
Circ Heart Fail,
September 1, 2009;
2(5):
490 - 498.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Robbers-Visser, L. Kapusta, L. van Osch-Gevers, J. L.M. Strengers, E. Boersma, Y. B. de Rijke, F. Boomsma, A. J.J.C. Bogers, and W. A. Helbing
Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years
J. Thorac. Cardiovasc. Surg.,
July 1, 2009;
138(1):
89 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Kerendi, Z. B. Kramer, W. T. Mahle, B. E. Kogon, K. R. Kanter, and P. M. Kirshbom
Perioperative Risks and Outcomes of Atrioventricular Valve Surgery in Conjunction With Fontan Procedure
Ann. Thorac. Surg.,
May 1, 2009;
87(5):
1484 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al.
Highlights of the Year in JACC 2008
J. Am. Coll. Cardiol.,
January 27, 2009;
53(4):
373 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Hsu and G. D. Pearson
Heart Failure in Children: Part I: History, Etiology, and Pathophysiology
Circ Heart Fail,
January 1, 2009;
2(1):
63 - 70.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Rosenthal
Three Studies Highlight Long-Term Follow-Up of Children After Fontan Procedure
AAP Grand Rounds,
December 1, 2008;
20(6):
65 - 67.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Backer
The Fontan Procedure: Our Odyssey Continues
J. Am. Coll. Cardiol.,
July 8, 2008;
52(2):
114 - 116.
[Full Text]
[PDF]
|
 |
|
|